CIK 0001833769
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Hyperfine, Inc.
Sign in to watch- Ticker
- HYPR
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 866-796-6767
- Business address
- 351 NEW WHITFIELD STREET, GUILFORD, CT, 06437
- Former names
- HealthCor Catalio Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,545
- in 2 filings
Net −$12,545. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-26 | Scott David D President and CEO | Grant or award | +649,350 | 799,350 | ||
| 2022-03-29 | Scott David D President and CEO | Grant or award | +150,000 | 150,000 | ||
| 2022-03-29 | Scott David D President and CEO | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2022-03-29 | Scott David D President and CEO | Grant or award · Stock Option (right to buy) | +474,875 | 474,875 | ||
| 2021-12-22 | Scott David D Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,899,500 | 1,899,500 | ||
| 2021-12-22 | Scott David D Chief Executive Officer | Grant or award · Stock Option (right to buy) | +474,875 | 474,875 | ||
| 2021-12-22 | Scott David D Chief Executive Officer | Grant or award · Stock Option (right to buy) | +474,875 | 474,875 |
Page 1 of 1 · 7 trades